Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). (Q33388438)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). |
scientific article |
Statements
1 reference
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). (English)
1 reference
Michael D Prados
1 reference
Lauren E Abrey
1 reference
Susan M Chang
1 reference
Nicholas A Butowski
1 reference
Fabio M Iwamoto
1 reference
Kathleen R Lamborn
1 reference
H Ian Robins
1 reference
Wei-Ting Zhang
1 reference
Howard A Fine
1 reference
3 March 2010
1 reference
1 reference
12
1 reference
855-861
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference